A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.
Total deaths from heart disease, stroke, diabetes and hypertension have been increasing since 2011, according to a new Northwestern Medicine study.
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
Low- and moderate-intensity exercise improved muscle, heart and breathing function in an animal model of Duchenne muscular dystrophy, according to a Northwestern Medicine study.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
Vincent Chen, a fourth-year medical student, was the first author of a study that estimated the lifetime risk for hypertension under new blood pressure thresholds.
Death rates due to heart failure are now increasing, and this increase is most prominent among younger adults under 65, according to a new study.
Robert Riestenberg, a third-year medical student, was the first author of a recent study that evaluated statin use among people with HIV, a population at an increased risk for cardiovascular disease.
Measures of structural changes derived from cardiac magnetic resonance imaging (CMR) have significant potential as a noninvasive way to measure the risk of heart transplant rejection, according to a new study.